Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Gains from Investment Securities (2023 - 2025)

Historic Gains from Investment Securities for Medinotec (MDNC) over the last 3 years, with Q4 2025 value amounting to $135441.0.

  • Medinotec's Gains from Investment Securities rose 88977.64% to $135441.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $970973.0, marking a year-over-year increase of 17164.73%. This contributed to the annual value of $737389.0 for FY2025, which is 21485.6% up from last year.
  • Medinotec's Gains from Investment Securities amounted to $135441.0 in Q4 2025, which was up 88977.64% from $193942.0 recorded in Q3 2025.
  • Over the past 5 years, Medinotec's Gains from Investment Securities peaked at $629458.0 during Q4 2023, and registered a low of -$1.3 million during Q1 2024.
  • Moreover, its 3-year median value for Gains from Investment Securities was $135441.0 (2025), whereas its average is $27246.6.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 9782.61% in 2024, then soared by 136847.88% in 2025.
  • Over the past 3 years, Medinotec's Gains from Investment Securities (Quarter) stood at $629458.0 in 2023, then plummeted by 97.83% to $13684.0 in 2024, then surged by 889.78% to $135441.0 in 2025.
  • Its Gains from Investment Securities was $135441.0 in Q4 2025, compared to $193942.0 in Q3 2025 and $262846.0 in Q2 2025.